EVŌQ Nano

evōq nano is a nanoscience company that engineers novel nanoparticles for the life science, materials science, and textile science industries. the company's multi-patented, high-volume laser nanofabrication process creates uniform, stable, sub-10nm nanoparticles with distinct surface chemistry suitable for a wide range of applications. evōq nano is currently focused on developing nanoparticles for 3 core industries: evōq bio has pioneered a nanomedicine platform with demonstrated antimicrobial efficacy against the world’s worst superbugs. in partnership with the cystic fibrosis foundation, the company has developed a lead therapeutic. the fda pre-ind meeting is anticipated for 2024. evōq medtech offers a breakthrough nanotechnology platform that integrates antimicrobial capabilities into medical devices to defend against a broad spectrum of contaminants like bacteria and fungi. the company has partnered with seven of the top catheter manufacturers with the aim of curbing hospital-